MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 254 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.

Quarter-by-quarter ownership
MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$3,039,857
-31.4%
113,132
-8.9%
0.04%
-26.0%
Q2 2023$4,428,081
+27.6%
124,175
-9.1%
0.05%
+22.0%
Q1 2023$3,471,596
-38.3%
136,677
-1.5%
0.04%
-41.4%
Q4 2022$5,629,890
+25.1%
138,804
+1.9%
0.07%
+14.8%
Q3 2022$4,501,000
-4.7%
136,195
+1.5%
0.06%0.0%
Q2 2022$4,725,000
-27.8%
134,205
-5.7%
0.06%
-12.9%
Q1 2022$6,546,000
-30.2%
142,328
+0.7%
0.07%
-26.3%
Q4 2021$9,375,000
+6.9%
141,403
+0.6%
0.10%
+9.2%
Q3 2021$8,773,000
-24.0%
140,520
+0.8%
0.09%
-23.7%
Q2 2021$11,546,000
+3.2%
139,409
-17.3%
0.11%
-2.6%
Q1 2021$11,183,000
-16.4%
168,640
-3.3%
0.12%
-23.0%
Q4 2020$13,383,000
+73.6%
174,414
-2.5%
0.15%
+47.6%
Q3 2020$7,707,000
+39.0%
178,973
+39.4%
0.10%
+32.1%
Q2 2020$5,544,000
+33.6%
128,363
-11.0%
0.08%
+13.0%
Q1 2020$4,149,000
-54.1%
144,212
+1.2%
0.07%
-40.0%
Q4 2019$9,035,000
+9026.3%
142,442
+3943.2%
0.12%
+11400.0%
Q3 2019$99,000
+10.0%
3,523
+3.2%
0.00%0.0%
Q2 2019$90,0003,4130.00%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
WESTERN FINANCIAL Corp 820,264$54,392,00033.22%
Johnson & Johnson Innovation - JJDC, Inc. 3,260,869$216,228,00028.00%
L1 Capital Pty Ltd 296,024$19,629,0004.93%
Aquilo Capital Management, LLC 407,926$27,050,0004.89%
Evolutionary Tree Capital Management, LLC 72,948$4,837,0002.86%
ACUTA CAPITAL PARTNERS, LLC 108,000$7,161,0002.58%
First Light Asset Management, LLC 536,836$35,598,0002.36%
Parkman Healthcare Partners LLC 70,089$4,648,0001.08%
Hood River Capital Management LLC 357,082$23,678,0000.76%
Tygh Capital Management, Inc. 63,947$4,240,0000.60%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders